Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02423954 · ClinicalTrials.gov registry record · Phase 1
Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)
A Phase 1 study, sponsored by Western Regional Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT02423954: Clinical Trial Phase 1 study, sponsored by Western Regional Medical Center.
NCT02423954 is a Phase 1 study that was terminated before completion, run by Western Regional Medical Center. The registered enrollment target is 33 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02423954, a Phase 1 study, was terminated before completion, sponsored by Western Regional Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
Determine Phase 2 dose of study drug
Primary Outcome
phase 2 dosing of nivolumab + chemotherapy
Interventions
- DRUG Irinotecan
- DRUG nivolumab
- DRUG Temsirolimus
- DRUG Irinotecan + capecitabine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-11-01 |
| Phase | Phase 1 |
Why NCT02423954 stopped before completion
NCT02423954 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (45% lower).
The record links to 0 conditions, and to 4 interventions - of which Irinotecan is the first listed.
NCT02423954 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02423954 about?
NCT02423954 is a clinical study titled "Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)". Determine Phase 2 dose of study drug
What is the current status of trial NCT02423954?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2015-04. Estimated completion is 2017-11-01.
What interventions are being tested in trial NCT02423954?
The interventions under investigation include: Irinotecan (DRUG), nivolumab (DRUG), Temsirolimus (DRUG), Irinotecan + capecitabine (DRUG).
Who is sponsoring clinical trial NCT02423954?
This trial is sponsored by Western Regional Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02423954's enrollment target sits among peer trials
33 1280th of 2000 higher than 705 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia